Drug Uses

Dovonex Cream is indicated for the treatment of plaque psoriasis.

How Taken

Apply a thin layer of Dovonex Cream to the affected skin twice daily and rub in gently and completely.

Warnings/Precautions

Use of Dovonex Cream may cause transient irritation of both lesions and surrounding uninvolved skin. If irritation develops, you should discontinue using Dovonex Cream. Do not use this medication for any disorder other than that for which it was prescribed.

Missed Dose

If you miss a dose, use it as soon as you remember. If it is near the time of the next dose, skip the missed dose and resume your usual dosing schedule. Do not double the dose to catch up.

Possible Side Effects

Some of the most frequent side effects that may occur while using Dovonex Cream are: skin irritation, rash, pruritus, dermatitis and worsening of psoriasis.

Storage

Store at controlled room temperature 15°C - 25°C (59°F - 77°F). Do not freeze.

Overdose

Topically applied Dovonex Cream can be absorbed in sufficient amounts to produce systemic effects. If an overdose is suspected, discontinue Donovex Cream and seek medical attention.

More Information

This medication is to be used only as directed by your physician. It is for external use only. Avoid contact with the face or eyes. As with any topical medication, you should wash your hands after application. Report to your physician any signs of adverse reactions.

Disclaimer

This drug information is for your information purposes only, it is not intended that this information covers all uses, directions, drug interactions, precautions, or adverse effects of your medication. This is only general information, and should not be relied on for any purpose. It should not be construed as containing specific instructions for any particular patient. We disclaim all responsibility for the accuracy and reliability of this information, and/or any consequences arising from the use of this information, including damage or adverse consequences to persons or property, however such damages or consequences arise. No warranty, either expressed or implied, is made in regards to this information.

Other info about Dovonex at Wikipedia.org and other resources:

Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2011
DUBLIN, Ireland, Aug. 5, 2011 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced its results for the quarter ended June 30, 2011. As discussed more fully below, our results of operations in the quarter ended June 30, 2011 as compared to the prior year quarter were impacted by several important transactions in recent periods. In 2011, these transactions included the refinancing of our senior secured indebtedness, the restructuring of certain of our Western European operations, and the repurposing of our Manati, Puerto Rico manufacturing facility. In prior year periods, the significant transactions included our acquisition of Novartis Pharmaceuticals Corporation's ("Novartis") U.S. rights to ENABLEX in October 2010 (the "ENABLEX Acquisition"), our acquisition of the global...

DOVONEX (Calcipotriene) Solution [LEO Pharma Inc.]
Updated Date: May 2, 2011 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

DOVONEX (Calcipotriene) Cream [Physicians Total Care, Inc.]
Updated Date: Feb 11, 2011 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

calcipotriene - topical, Dovonex
Title: calcipotriene - topical, DovonexCategory: MedicationsCreated: 3/2/2005Last Editorial Review: 9/22/2010 (Source: MedicineNet Skin General)

DOVONEX (Calcipotriene) Solution [LEO Pharma Inc.]
Updated Date: Jul 7, 2010 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))